How to use the speech recognition tool?
A Dose Escalation (Phase 1), and Dose Expansion (Phase 2/3) Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using an Adeno-Associated Viral Vector (AAV8) Encoding Retinitis Pigmentosa GTPase Regulator (RPGR).
Status of the trial: Completed
Orphan Drug Recognition: No
Funder Type: industry
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators